80% of people worldwide are below cardioprotective levels of omega-3s.

Research supports the importance of EPA and DHA for a variety of cardiovascular outcomes, including reducing the risk of coronary heart disease, myocardial infarction and cardiac death.

A 2020 meta-analysis on the topic was published in Mayo Clinic Proceedings.

Learn more here

See resources below, or ask us about the many more reasons to recommend omega-3s for your patient's heart.

View all resources